~Iri,n - Bayhdolecentral
~Iri,n - Bayhdolecentral
~Iri,n - Bayhdolecentral
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
42 I Journalof the Association of University Technology Managers<br />
funding agency of and timely filing patents on disclosed inventions in<br />
the United States, as well as countries outside of the United States.<br />
• Undertake periodic internal due diligence reviews to check for compliance<br />
with Bayh-Dole Act obligations, especially with regard to<br />
federally funded research where invention disclosures have already<br />
been submitted, patents are pending; etc. While this may be considered<br />
burdensome to do, the consequences of overlooking a failure to com<br />
ply can be grave indeed. If a problem is discovered promptly enough,<br />
there may even be time to take remedial action to avoid the potential<br />
loss of rights.<br />
• Take prompt action to try: to remedy anyfailure to comply with Bayh<br />
Dole Act obligations. All is not necessarily lost if such a failure is<br />
discovered in time, and a diligent, good faith effort is made to come into<br />
compliance. For example, if a subject invention was submitted to the<br />
university patent administrator more than two months earlier but<br />
before the patent is filed, promptly disclose that subject invention (on<br />
the correct fonn) to the funding agency. Most funding agencies are not<br />
interested in and do not have the resources to exploit inventions from<br />
federally funded extramural research, and some may not even be aware<br />
of the university's obligations under the Bayh-Dole Act. Again, the<br />
funding agency is more likely to exercise its "discretion'' not to take title<br />
if the university proactively tries to remedy what may be a technical<br />
failure to comply with the Bayh-Dole Act.<br />
Campbell Plastics may prompt funding agencies to focus more on the<br />
obligations of contractors, including universities and other nonprofit<br />
research institutions, under the Bayh-Dole Act. Indeed, this potentially<br />
heightened scrutiny could draw unwanted attention to these obligations<br />
under the Bayh-Dole Act for those who are recipients of federal funding.<br />
Congress may eventually reevaluate whether the arguably draconian results<br />
of Campbell Plastics ate a fair and equitable way to obtain compliance, as<br />
well as articulate how much discretion should be vested in a funding agency<br />
for failure to comply. Meanwhile, universities need to be prepared and<br />
proactive to avoid losing valuable patent rights in federally funded research,<br />
as well as suffering other undesirable consequences from a failure to<br />
comply with the Bayh-Dole Act.